Merck delays filing for combo cholesterol drug
524021
Merck & Co.  said on Friday it would delay seeking approval for a combination pill designed to lower "bad" cholesterol, increase "good" cholesterol and avoid a common side effect of one of the ingredients.
388679
A long, suspicious delay in the study of Merck and Schering's $5 billion drug was reported by Forbes in November.
73292
Federal advisers rejected Merck &amp; Co.'s quest to become the first American drug maker to sell cholesterol-fighting statins over the counter, saying the company's own studies raised potential health risks while offering modest life-saving benefits.
87010
New data are due out on a promising cholesterol drug. But there are doubters.
733605
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc  and Schering-Plough's  cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
606459
Genentech said that approval of its colon cancer drug Avastin as a treatment for breast cancer would be delayed by at least a year.
407294
The biotech company announces new drug delays.
526924
Momenta announces a delay in the FDA review of its lead drug.
377266
WASHINGTON (CBS.MW) -- A government official who first warned of dangers in Merck&#39;s arthritis drug Vioxx is now pointing a finger at Bayer AG, charging that the firm held back evidence of a deadly side effect of its cholesterol drug Baycol.
672466
SILVER SPRING, Maryland  - Making a cholesterol drug available over the counter could give millions of Americans a new option to reduce the risk of heart disease and provide a major public health benefit, drugmaker Merck & Co Inc argued to a U.S. advisory panel on Thursday.
102166
U.S. regulators on Friday delayed a  decision on whether to approve over-the-counter sales of a Barr  Pharmaceuticals "morning-after pill" to prevent pregnancy,  prompting a lawsuit from a women's rights group.
453956
A Delaware Chancery Court judge  said on Friday that Caremark Rx Inc.  must delay a  shareholder vote until the pharmacy benefit manager provides  more details on its planned acquisition by CVS Corp.
522767
Arena Pharmaceuticals, Inc.   said on Monday that Merck & Co. Inc.  has  pulled out of a partnership to develop an experimental drug for  atherosclerosis after results from a mid-stage clinical trail.
458999
Merck & Co.  said on Friday it  would delay seeking approval for a combination pill designed to  lower "bad" cholesterol, increase "good" cholesterol and avoid  a common side effect of one of the ingredients.
494061
BETHESDA, Md.  - A U.S. advisory panel on Friday  urged regulators to reject over-the-counter sales of Merck &  Co. Inc.'s MRK.N cholesterol-lowering drug Mevacor.
695798
Yet another delay from the FDA leaves investors hanging.
38442
Merck & Co. is making a third try to sell the granddaddy of the famed cholesterol-lowering statin drugs without a prescription.